Jon Faldasz: Ondansetron May Have Cardiotoxicity Risk Among 5-HT3RAs Due to High Concentration in Cardiac Tissues
Jon Faldasz, Senior Director of Product and Customer Experience at InsightRX, posted on LinkedIn:
”Just dropped: Ondansetron may have outstanding cardiotoxicity risk among 5-HT3RAs due to high concentration in cardiac tissues
Published today in Nature Scientific Reports, Cai et al used the FDA’s Adverse Event Reporting System (FAERS) to review records of cardiotoxicity associated with 5-HT3RA use. They found:
– The different 5-HT3RAs exhibit varying degrees and types of cardiotoxicity
– QT prolongation was most common for ondansetron (granisetron was least common)
– In a subsequent PBPK model extrapolation they estimated that ondansetron concentrations in cardiac tissue were 2.3x higher than plasma.
They suggested that providers might “prioritize low cardiac toxicity 5-HT3RAs” (read: avoid ondansetron) in patients with heart disease.
For my part, FAERS seems like an untapped resource for this type of work, now I’m thinking on what other investigations could make use of it.
Article reference here.”
Title: Cardiotoxicity of different 5-HT3 receptor antagonists analyzed using the FAERS database and pharmacokinetic study
Authors: Yijun Cai, Shaohong Luo, Shen Lin, Xiaoting Huang, Xiangzhen Wang, Lijing Yang, Xiongwei Xu, Xiuhua Weng
Stay updated with Hemostasis Today.
-
Nov 21, 2025, 14:26Haroun Gajraj: Stop Before You Inject Spider Veins Around the Ankle
-
Nov 21, 2025, 14:26Michael Makris: New UK Guideline on Acquired Coagulation Factor Inhibitors
-
Nov 21, 2025, 14:24William Wallace: Magnesium – Role in Blood Pressure Regulation
-
Nov 21, 2025, 14:23Mohamed Magdy Badr: How Do Acute Wounds Turn Into Chronic Wounds?
-
Nov 21, 2025, 14:22Ron DePinho: A Transformative Insight into Lupus – and the Virus Nearly All of Us Carry
-
Nov 21, 2025, 14:18Michael Bartholomew: Fix Your Mitochondria, Fix Almost Everything
-
Nov 21, 2025, 14:16Gianluca Franceschini on Fostering Innovation in Breast Cancer Care
-
Nov 21, 2025, 14:10Hortense Triniac Shares PhD Research: How Cortical Neurons Process and Activate tPA
-
Nov 21, 2025, 14:09Tatevik Hovakimyan and Rachel ter Bekke: Modern Insights into Cardiomyopathies and Channelopathies